{"cell_type":{"ad84da08":"code","956dc13c":"code","a095cc2c":"code","8cbf4b63":"code","b0ab1570":"code","aba02d0f":"code","3ff2dc75":"code","3a2a7cf5":"code","20116c4f":"code","e2d1f82a":"code","376b7e74":"code","5d3870f3":"code","d58d24d5":"code","adf1f49f":"code","030740ec":"code","6a4556b3":"code","3e5039d9":"code","4cb4696e":"code","8f5eaedf":"code","af3c1861":"code","367afd59":"code","a5e68ae5":"code","c459bb70":"markdown","95308be1":"markdown","1272bb4c":"markdown","38076a73":"markdown","b61a877e":"markdown","6c937a64":"markdown","16ab6854":"markdown","10679bc9":"markdown","6bf02489":"markdown","f7def56e":"markdown","de7e00b8":"markdown","308ec2a2":"markdown","8e92e035":"markdown","8884511d":"markdown","13357b3a":"markdown","0149e03a":"markdown","1025591a":"markdown","376cb628":"markdown","7fe8bc31":"markdown"},"source":{"ad84da08":"#codes from Rodrigo Lima  @rodrigolima82\nfrom IPython.display import Image\nImage(url = 'data:image\/png;base64,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',width=400,height=400)","956dc13c":"# This Python 3 environment comes with many helpful analytics libraries installed\n# It is defined by the kaggle\/python docker image: https:\/\/github.com\/kaggle\/docker-python\n# For example, here's several helpful packages to load in \n\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I\/O (e.g. pd.read_csv)\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I\/O (e.g. pd.read_csv)\nimport matplotlib.pyplot as plt\nimport seaborn as sns\nfrom sklearn import feature_extraction, linear_model, model_selection, preprocessing\nimport plotly.graph_objs as go\nimport plotly.offline as py\nimport plotly.graph_objs as go\nimport plotly.figure_factory as ff\n\n# Input data files are available in the \"..\/input\/\" directory.\n# For example, running this (by clicking run or pressing Shift+Enter) will list all files under the input directory\n\nimport os\nfor dirname, _, filenames in os.walk('\/kaggle\/input'):\n    for filename in filenames:\n        print(os.path.join(dirname, filename))\n\n# Any results you write to the current directory are saved as output.","a095cc2c":"df1 = pd.read_csv('..\/input\/diabetes\/diabetes.csv', encoding='ISO-8859-2')\n\ndf1.head()","8cbf4b63":"df = pd.read_csv('..\/input\/cancer-data-2017\/cancer2017.csv', encoding='ISO-8859-2')\n\ndf.head()","b0ab1570":"#The evolution of results From Tawej https:\/\/www.kaggle.com\/tawejssh\/covid-19 Graph China\/italy\ncindicators = df.groupby('State').sum()[['Brain\/ nervous system', 'Female breast', 'Colon & rectum', 'Leukemia', 'Liver', 'Lung & bronchus', 'Non-Hodgkin Lymphoma', 'Ovary', 'Pancreas', 'Prostate']]\n#evolution['Expiration Rate'] = (evolution['Expired'] \/ evolution['Cumulative']) * 100\n#evolution['Discharging Rate'] = (evolution['Discharged'] \/ evolution['Cumulative']) * 100\ncindicators.head()","aba02d0f":"plt.figure(figsize=(20,7))\nplt.plot(cindicators['Lung & bronchus'], label='Lung cancer')\nplt.plot(cindicators['Female breast'], label='Breast cancer')\nplt.plot(cindicators['Colon & rectum'], label='Colon cancer')\nplt.plot(cindicators['Prostate'], label='Prostate cancer')\nplt.plot(cindicators['Liver'], label='Liver cancer')\nplt.legend()\n#plt.grid()\nplt.title('Types of Cancer')\nplt.xticks(cindicators.index,rotation=45)\nplt.xlabel('States')\nplt.ylabel('Cancer Types')\nplt.show()","3ff2dc75":"#What about the evolution of China Diagnosed Worldometer rate ?\nplt.figure(figsize=(20,7))\nplt.plot(cindicators['Lung & bronchus'], label='Lung cancer')\nplt.legend()\nplt.grid()\nplt.title('Lung cancer')\nplt.xticks(cindicators.index,rotation=45)\nplt.ylabel('Rate %')\nplt.show()","3a2a7cf5":"y=list(df.columns)\n#bdf=df.copy()\n#for col in range(1,len(y)):\n #   bdf[y[col]].fillna((bdf[y[col]].mean()), inplace=True)\n#bdf.head()","20116c4f":"# Code from Mohamed Sharbudeen  https:\/\/www.kaggle.com\/iamsharbu\/cancer2017\nx='State'\ni=1\nz=[\"prostate\",\"brain\",\"breast\",\"colon\",\"leukemia\",\"liver\",\"lung\",\"lymphoma\",\"ovary\",\"pancreas\"]\nfig,ax=plt.subplots(nrows=5,ncols=2,figsize=(20,20))\nfig.suptitle('Incomplete Data Set')\nfor row in ax:\n    for col in row:\n        col.plot(df[x],df[y[i]])\n        i=i+1\ni=0\nfor ax in fig.axes:\n    plt.xlabel('States')\n    plt.ylabel(\"no of people affected\")\n    plt.title(z[i])\n    i=i+1\n    plt.sca(ax)\n    plt.xticks(rotation=90)\n    plt.grid()\n    plt.subplots_adjust(left=None, bottom=None, right=None, top=None, wspace=None, hspace=1)\nfig.tight_layout()\nfig.subplots_adjust(top=0.95)\nplt.show()","e2d1f82a":"i=1\nfig,ax=plt.subplots(nrows=5,ncols=2,figsize=(20,20))\nfig.suptitle('Incomplete Data Set')\n\nfor row in ax:\n    for col in row:\n        col.bar(df[x],df[y[i]])\n        i=i+1\ni=0\nfor ax in fig.axes:\n    plt.xlabel('States')\n    plt.ylabel(\"no of people affected\")\n    plt.title(z[i])\n    i=i+1\n    plt.sca(ax)\n    plt.xticks(rotation=90)\n    plt.grid()\n    plt.subplots_adjust(left=None, bottom=None, right=None, top=None, wspace=None, hspace=1)\n\nfig.tight_layout()\nfig.subplots_adjust(top=0.95)\nplt.show()","376b7e74":"cnt_srs = df['Lung & bronchus'].value_counts().head()\ntrace = go.Bar(\n    y=cnt_srs.index[::-1],\n    x=cnt_srs.values[::-1],\n    orientation = 'h',\n    marker=dict(\n        color=cnt_srs.values[::-1],\n        colorscale = 'Greens',\n        reversescale = True\n    ),\n)\n\nlayout = dict(\n    title='Lung Cancer',\n    )\ndata = [trace]\nfig = go.Figure(data=data, layout=layout)\npy.iplot(fig, filename=\"Lung & bronchus\")","5d3870f3":"cnt_srs = df['Female breast'].value_counts().head()\ntrace = go.Bar(\n    y=cnt_srs.index[::-1],\n    x=cnt_srs.values[::-1],\n    orientation = 'h',\n    marker=dict(\n        color=cnt_srs.values[::-1],\n        colorscale = 'armyrose',\n        reversescale = True\n    ),\n)\n\nlayout = dict(\n    title='Breast Cancer',\n    )\ndata = [trace]\nfig = go.Figure(data=data, layout=layout)\npy.iplot(fig, filename=\"Female breast\")","d58d24d5":"cnt_srs = df['Colon & rectum'].value_counts().head()\ntrace = go.Bar(\n    y=cnt_srs.index[::-1],\n    x=cnt_srs.values[::-1],\n    orientation = 'h',\n    marker=dict(\n        color=cnt_srs.values[::-1],\n        colorscale = 'magenta',\n        reversescale = True\n    ),\n)\n\nlayout = dict(\n    title='Colon & rectum Cancer',\n    )\ndata = [trace]\nfig = go.Figure(data=data, layout=layout)\npy.iplot(fig, filename=\"Colon & rectum\")","adf1f49f":"cnt_srs = df['Prostate'].value_counts().head()\ntrace = go.Bar(\n    y=cnt_srs.index[::-1],\n    x=cnt_srs.values[::-1],\n    orientation = 'h',\n    marker=dict(\n        color=cnt_srs.values[::-1],\n        colorscale = 'teal',\n        reversescale = True\n    ),\n)\n\nlayout = dict(\n    title='Prostate Cancer',\n    )\ndata = [trace]\nfig = go.Figure(data=data, layout=layout)\npy.iplot(fig, filename=\"Prostate\")","030740ec":"#Code from Prashant Banerjee @Prashant111\nlabels = df['State'].value_counts().index\nsize = df['State'].value_counts()\ncolors=['#BF3F3F','#3F3FBF']\nplt.pie(size, labels = labels, colors = colors, shadow = True, autopct='%1.1f%%',startangle = 90)\nplt.title('State', fontsize = 20)\nplt.legend()\nplt.show()","6a4556b3":"#Codes from Saurav Anand https:\/\/www.kaggle.com\/saurav9786\/eda-makes-sense\n\nfig=plt.figure(figsize=(20,3))\n\nfor i in np.arange(1,7):\n    data=plt.subplot(1,7,i,title=df1.columns[i])\n    sns.boxplot(df1[df1.columns[i]])","3e5039d9":"#Codes Nasir Islam Sujam https:\/\/www.kaggle.com\/nasirislamsujan\/intro-to-plotly\/data\nimport plotly","4cb4696e":"#Codes Nasir Islam Sujam https:\/\/www.kaggle.com\/nasirislamsujan\/intro-to-plotly\/data\ntrace0 = go.Box(\n    name = 'Pregnancies',\n    y = df1[\"Pregnancies\"]\n)\n\ntrace1 = go.Box(\n    name = \"Glucose\",\n    \n    y = df1[\"Glucose\"]\n)\n\ntrace2 = go.Box(\n    name = \"BloodPressure\",\n    y = df1[\"BloodPressure\"]\n)\n\ntrace3 = go.Box(\n    name = \"SkinThickness\",\n    y = df1[\"SkinThickness\"]\n)\n\ntrace4 = go.Box(\n    name = \"Insulin\",\n    y = df1[\"Insulin\"]\n)\n\ntrace5 = go.Box(\n    name = \"DiabetesPedigreeFunction\",\n    y = df1[\"DiabetesPedigreeFunction\"]\n)\n\ntrace6 = go.Box(\n    name = \"Age\",\n    y = df1[\"Age\"]\n)\n\ntrace7 = go.Box(\n    name = \"Outcome\",\n    y = df1[\"Outcome\"]\n)\n\ndata = [trace0, trace1, trace2, trace3, trace4, trace5, trace6, trace7]\nplotly.offline.iplot(data)","8f5eaedf":"#Codes Nasir Islam Sujam https:\/\/www.kaggle.com\/nasirislamsujan\/intro-to-plotly\/data\ncolumn_names = df1.columns\n\ny_data = df1[df1.columns].values\n\ncolors = ['rgba(93, 164, 214, 0.5)', 'rgba(255, 144, 14, 0.5)', 'rgba(44, 160, 101, 0.5)',\n          'rgba(255, 65, 54, 0.5)', 'rgba(207, 114, 255, 0.5)', 'rgba(127, 96, 0, 0.5)',\n          'rgba(255, 140, 184, 0.5)', 'rgba(79, 90, 117, 0.5)', 'rgba(222, 223, 0, 0.5)']\n\ntraces = []\n\nfor col_name, yd, color in zip(column_names, y_data, colors):\n        traces.append(go.Box(\n            y = yd,\n            name = col_name,\n            boxpoints = 'all',\n            jitter = 0.5,\n            whiskerwidth = 0.2,\n            fillcolor = color,\n            marker = dict(\n                size = 2,\n            ),\n            line = dict(width = 1),\n        ))\n\ndata=traces\nplotly.offline.iplot(data)","af3c1861":"N = 2000\n\nrandom_x = np.random.randn(N)\nrandom_y = np.random.randn(N)\n# Create a trace\ntrace = go.Scatter(\n    x = random_x,\n    y = random_y,\n    mode = 'markers'\n)\n\ndata = [trace]\n\n#plotly.offline.iplot(data, filename='basic-scatter')","367afd59":"#Codes Nasir Islam Sujam https:\/\/www.kaggle.com\/nasirislamsujan\/intro-to-plotly\/data\nx_data = df1[\"Glucose\"]\ny_data = df1[\"Insulin\"]\ncolors = np.random.rand(2938)\nsz = np.random.rand(N)*30\n\nfig = go.Figure()\nfig.add_scatter(x = x_data,\n                y = y_data,\n                mode = 'markers',\n                marker = {'size': sz,\n                         'color': colors,\n                         'opacity': 0.6,\n                         'colorscale': 'Portland'\n                       })\nplotly.offline.iplot(fig)","a5e68ae5":"#codes from Rodrigo Lima  @rodrigolima82\nfrom IPython.display import Image\nImage(url = 'data:image\/jpeg;base64,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',width=400,height=400)","c459bb70":"Report of the WHO-China Joint Mission on Coronavirus Disease published on February 28, 2020. \nhttps:\/\/www.who.int\/publications-detail\/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)\n\nThis report indicates that in China, as of the data cut-off (February 20) the case fatality rate for patients with cancer as a comorbid condition and laboratory confirmed infection was 7.6%.  This is as compared to: overall 3.8%, no comorbid condition 1.4%, cardiovascular disease 13.2%, diabetes 9.2%, hypertension 8.4%, chronic respiratory disease 8.0%.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","95308be1":"#Are Diabetes, CVD Associated With Worse COVID-19 Prognosis?\n\nAuthors: CME Authors: Laurie Barclay, MD and Esther Nyarko, PharmD\n\nDeath rate was elevated among those with preexisting comorbid conditions: 10.5% for CVD, 7.3% for diabetes, 6.3% for chronic respiratory disease, 6.0% for hypertension, and 5.6% for cancer.\nhttps:\/\/www.medscape.org\/viewarticle\/926097","1272bb4c":"In addition to the general CDC guidance, the following practice points may be considered:\n\nPatients should be informed regarding the symptoms of COVID-19, and trained in proper handwashing, hygiene, and minimizing exposure to sick contacts and large crowds.\n\nAt this time, no specific evidence or guidance on mask use in patients with cancer patients has been published. Patients and clinicians are urged to follow the USCDC\u2019s general recommendations on mask wear. There is no guidance or evidence to suggest that N95 masks are required.\n\nFor cancer patients with fever or other symptoms of infection, a comprehensive evaluation should be performed, as per usual medical practice.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","38076a73":"#How should the care of cancer patients be modified by the COVID-19 pandemic?\n\nWhat are the current data on care of patients with cancer and COVID-19?  Are patients with cancer more likely to be infected? Do they have more complications?\n\nThe CDC is best source of information (Accessed March 13 2020). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/how-covid-spreads.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fabout%2Findex.html\n","b61a877e":"#Can\/should surgery be cancelled or delayed?\n\nIf surgery is delayed, should patients be started earlier on neoadjuvant therapy if that is an available option?\n\nThe CDC\u2019s guidance for health care facilities suggests that \u201celective surgeries\u201d at in-patient facilities be rescheduled if possible.  The American College of Surgeons (ACS) has issued guidance as well and provides additional advice related to triage of patients for surgery relevant to cancer care.  However, clinicians and patients will need to make individual determinations based on the potential harms of delaying needed cancer-related surgery; in many cases these surgeries cannot be considered \u201celective\u201d. Also, if the surgery requires post-operative intensive care, the current capacity of the intensive care units available for that care should be considered as part of decision making.  The Society of Surgical Oncology (SSO) has released brief guidance on surgery for cancer for a number of different tumor types.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","6c937a64":"#Radiation: Can\/should the initiation of radiation be delayed?\n\nCan radiation be interrupted or postponed if already in progress?\n\nAs noted by ASTRO (American Society for Radiation Oncology), if hypofractionated schedules are considered reasonable, they should be considered. ASCO (American Society of Clinical Oncology)recognizes the risks of delay in treatment for patients with rapidly progressing, potentially curable tumors may outweigh the risks of COVID-19 exposure\/infection, but patients receiving radiation for symptom control or at low risk of harm due to alteration of schedule for radiation treatment visits could potentially be safely delayed.  Patients should check with their radiation oncologist to determine the most appropriate course of action for their treatment.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","16ab6854":"esmo.org","10679bc9":"#CANCER-TYPE SPECIFIC GUIDANCE: How should care for patients with cancer types be affected?\n\nASCO will link to such guidance as other organizations publish it.\n\nBreast cancer \u2013 The American Society of Breast Surgeons has published brief, high level guidance on prioritization for care in breast cancer. In addition, the Americal College of Surgeons has published guidance on triage of patients with breast cancer for surgery. \n\nHematological malignancy \u2013 The American Society of Hematology has released guidance related to a number of different malignancies.\n\nSurgery \u2013 The Society of Surgical Oncology has published brief guidance on surgery for a number of different disease sites, it can be found on their website.\n \nThere is no specific guidance with respect to COVID-19 testing in patients with cancer. The Infectious Disease Society of America (IDSA) has published some guidance on testing. (accessed March 13, 2020). The CDC also has information for laboratories here (accessed March 13, 2020).\nhttps:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","6bf02489":"#Should cancer therapy be delayed in patients who are infected with COVID-19?\n\nPatients receiving anti-cancer treatment and infected with influenza and other viruses are potentially at risk for serious complications such as pneumonia and hospitalization. In the recent paper by Zhang et al in Annals of Oncology, a strong association between anti-cancer therapy in the past 14 days and severe effects of COVID-19 infection was reported (HR=4.079, 95%CI 1.086-15.322, P=0.037) in 28 patients.  Although these data are limited, interrupting anti-cancer treatment in patients with active COVID-19 should be strongly considered as continuation of treatment may lead to further immunosuppression and risk for serious complications.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","f7def56e":"who.int","de7e00b8":"#Can\/should treatment with immune checkpoint inhibitors (e.g. ipilimumab, nivolumab) be delayed or interrupted?\n\nAre any special precautions or actions needed with respect to their use?\n\nASCO is not aware of data specific to immune checkpoint inhibitors and COVID-19 infection.  It may be appropriate to adjust to less frequent dosing intervals when different schedules are considered reasonable options and\/or are approved in your jurisdiction for the patient\u2019s indication. \n\nHowever, as these agents may cause immune-related serious adverse events and immunosuppression may not be advisable as a treatment for those events, the potential harms and benefits of therapy should be considered for each patient.  Of particular concern is treatment-related pneumonitis, which may increase the chance of serious complications should the patient develop COVID-19.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","308ec2a2":"#Dialysis Should Continue Despite COVID-19; CDC Gives Guidance\n\nUpdated guidance from the US Centers for Disease Control and Prevention (CDC) details key strategies for managing patients who have COVID-19 on renal dialysis \u2014 a population whose unique vulnerability is underscored by the fact that the first two patients in the United States known to have died from COVID-19 were in fact outpatients at dialysis centers in the Seattle area.\n\n\"In the United States, we have seen some scattered reports and we know...a handful of people who have become COVID-19 positive are dialysis patients, but we haven't had any reports of any widespread transmissions among dialysis patients in any specific area \u2014 but we're staying alert,\"\n\nAmid the ever-increasing alarm, however, is the key message to dialysis centers of the need to balance strict precautions while making sure patients are able to continue dialysis treatment.\n\nIn addition to those who are elderly and with chronic diseases such as diabetes and heart disease, patients with chronic kidney disease are also suspected to be at higher risk of succumbing to COVID-19.\nhttps:\/\/www.medscape.com\/viewarticle\/926720#vp_3","8e92e035":"#Other Relevant Questions\n\nShould prophylactic antiviral therapy be considered?\n\nAre there any concerns or issues surrounding concomitant medications for patients with cancer?\n\nHow should care of survivors of cancer with long term immune suppression (e.g. hypogammaglobulinemia) be altered?\n\nAre there any other therapies that should be delayed, interrupted, or stopped?\n\nHow can\/should care for patients experiencing potential neutropenic fever and neutropenia be affected by the ongoing COVID-19 pandemic?\n\nHow can\/should care for patients at risk for or experiencing cancer-related anemia be affected by the ongoing COVID-19 pandemic? \n\nHow can can\/should the central venous catheters\/ports be maintained?  Can flushing be delayed?\n\n#Can\/should members of the community continue recommended cancer screening activities (e.g. screening mammography)?\n\nHow can\/should diagnosis and staging interventions (e.g. imaging visits, biopsy) be modified by the ongoing COVID-19 pandemic?  Is there any evidence that COVID-19 infection influences the ability to diagnosis or stage disease (e.g. chest imaging for potential lung cancer)?\n\nCan\/should patients receiving ongoing surveillance (e.g. imaging for detection of recurrence, active surveillance for existing disease) have that surveillance delayed\/interrupted?\nhttps:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19\n ","8884511d":"#Code from Mohamed Sharbudeen  https:\/\/www.kaggle.com\/iamsharbu\/cancer2017","13357b3a":"#Can\/should allogeneic stem cell transplantation be delayed?\n\nIn some cases involving patients at high-risk for COVID-19, delaying a planned allogeneic SCT may be reasonable, particularly if the patient\u2019s malignancy is controlled with conventional treatment. Until further data are available, clinicians are encouraged to follow the recommendations provided by the American Society of Transplantation and Cellular Therapy (ASTCT); and the European Society for Blood and Marrow Transplantation (EBMT) recommendations with respect to stem cell transplantation.\n\nThe following practice points may be considered:\n\nTest potential donors for COVID-19 even in an absence of evidence of transmission by blood transfusion.\n\nAs a general precaution, visitation post-transplant may need to be limited and visitors may need to be screened for symptoms and potential exposure.https:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","0149e03a":"Kaggle Notebook Runner: Mar\u00edlia Prata  @mpwolke","1025591a":"#Case Fatality Rate for Diabetes Is High, but Interpretation Is Tricky\n\nEvidence suggests that diabetes may increase risk for infection from COVID-19 by 2- to 3-fold, independent of other medical problems such as CVD.(Cardio Vascular Disease). \n\n\"In general, diabetes can be a marker of other chronic health conditions like heart disease, as well as obesity, which might contribute to the increased risk of infection,\" \"Diabetes is also much more common with age and will continue to be a marker of poor outcomes for these reasons,\"https:\/\/www.medscape.org\/viewarticle\/926097","376cb628":"#Can\/should immunosuppressive therapy (except allogenic stem cell transplantation) be stopped, delayed, or interrupted?\n\nAt this time, there is no direct evidence to support changing or withholding chemotherapy or immunotherapy in patients with cancer. Therefore, routinely withholding critical anti-cancer or immunosuppressive therapy is not recommended. The balance of potential harms that may result from delaying or interrupting treatment versus the potential benefits of possibly preventing or delaying COVID-19 infection is very uncertain. Clinical decisions should be individualized that consider factors such as the risk of cancer recurrence if therapy is delayed, modified or interrupted; the number of cycles of therapy already completed; and the patient\u2019s tolerance of treatment. \n\nHowever, the following practice points should be considered: \n\nDeep remission,stopping chemotherapy may be an option.\nSwitching chemotherapy from IV to oral therapies.\nHome infusion of chemotherapy drugs when medically and logistically feasible.\n\nhttps:\/\/www.asco.org\/asco-coronavirus-information\/care-individuals-cancer-during-covid-19","7fe8bc31":"#Poor Control of Diabetes a Risk Factor for Infection. Each Person With Diabetes Is Different; Use Common Sense.\n\nCertainly a person with both diabetes and would have more risk than someone with diabetes and good glucose control and without any other comorbidities,\" But because every person with diabetes is different, it is important to consider the whole package.\n\nWhether someone with diabetes succumbs to infection has a lot to do with glycemic control, diabetes duration, and diabetes-related comorbid conditions, such as heart disease, kidney disease, and stroke, as well as their age, their weight, and whether they smoke. \n\nIndications so far are that there is a worse prognosis for people with diabetes and other chronic medical conditions, such as CVD, if they become infected with COVID-19. \n\nStatistics suggest that those who are the most vulnerable (ie, the elderly, people with comorbid conditions such as uncontrolled diabetes and CVD) can have a worse prognosis. More detailed analysis is needed, however, to show a clear connection between the two.\n\nDr Chan, Dr Luk, and Dr Malani have disclosed no relevant financial relationships. JAMA. Published online February 24, 2020.\n\nhttps:\/\/www.medscape.org\/viewarticle\/926097"}}